<PAGE> 1
OMB APPROVAL
OMB Number: 3235-0145
Expires: October 31, 1994
Estimated average burden
hours per response..14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Genovese Drug Stores, Inc.
--------------------------
(Name of Issuer)
Class A Common Stock, par value $1.00 per share
-----------------------------------------------
(Title of Class of Securities)
372442202
--------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement [ ]. (A fee
is not required only if the filing person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
- ---------------------------
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
<PAGE> 2
Page 2 of 6 Pages
CUSIP No. 372442202 13G
---------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Geraldine Genovese
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
NUMBER OF 5 SOLE VOTING POWER
SHARES 1,566
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 49,595
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 1,566
PERSON WITH 8 SHARED DISPOSITIVE POWER
49,595
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
51,161 (see Annex A)
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES*
[ ]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
1.2%
12 TYPE OF REPORTING PERSON*
IN
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE> 3
Page 3 of 6 Pages
Item 1(a). Name of Issuer:
Genovese Drug Stores, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
80 Marcus Drive
Melville, NY 11747
Item 2(a). Name of Person Filing:
Geraldine Genovese
Item 2(b). Address of Principal Business Office or, if None, Residence:
80 Marcus Drive
Melville, NY 11747
Item 2(c). Citizenship:
United States of America
Item 2(d). Title of Class of Securities:
Class A Common Stock, par value $1.00 per share
Item 2(e). CUSIP Number:
372442202
Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b),
check whether the person filing is a:
Not applicable
Item 4. Ownership
(a) Amount Beneficially Owned
51,161 (see Annex A)
(b) Percent of Class
1.2%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote
1,566
<PAGE> 4
Page 4 of 6 Pages
(ii) shared power to vote or to direct the vote
49,595
(iii) sole power to dispose or to direct the
disposition of
1,566
(iv) shared power to dispose or to direct the disposition of
49,595
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check
the following [X].
Item 6. Ownership of More than Five Percent on Behalf of another Person
Not Applicable
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on By the Parent Holding Company
Not applicable
Item 8. Identification and Classification of Members of the Group
Not applicable
Item 9. Notice of Dissolution of Group
Not applicable
Item 10. Certification
Not applicable
<PAGE> 5
Page 5 of 6 Pages
SIGNATURE
After reasonable inquiry to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
November 9, 1994
----------------------
Date
/s/ Geraldine Genovese
----------------------
Signature
Geraldine Genovese
----------------------
Name/Title
<PAGE> 6
Page 6 of 6 Pages
ANNEX A TO SCHEDULE 13G OF GERALDINE GENOVESE
All of the number of shares shown as beneficially owned by the reporting person
are beneficially owned in the form of the Issuer's Class B Common Stock, par
value $1.00 per share, which class is not registered as a class of equity
securities under the Securities Exchange Act of 1934 but which can be converted
within 60 days into an equal number of shares of the Issuer's Class A Common
Stock.
All of the number of shares shown as beneficially owned by the reporting person
are held by the reporting person as trustee or co-trustee under certain trusts
for the benefit of Mary Margaret Genovese, the daughter of the reporting
person. The reporting person disclaims beneficial ownership of all such
shares.
